
Bioenhancer Systems is a UK-based company that empowers biotech and biomedical research institutions with state-of-the-art predictive modeling and bioinformatics solutions. Their core technology focuses on genomics, proteomics, transcriptomics, and systems biology, enhanced by machine learning and AI. They offer a user-friendly, AI-driven platform for building predictive models and have developed specific software tools like DPhenomics, MSDanalyser, and BMfinder. Their business model is primarily SaaS, with solutions offered as microservices via API or online platforms, utilizing personalized subscription plans. The company is actively involved in scientific publication and software releases, aiming to improve biomarker discovery, diagnostics, prognostics, and therapy assessment in areas like precision medicine.

Bioenhancer Systems is a UK-based company that empowers biotech and biomedical research institutions with state-of-the-art predictive modeling and bioinformatics solutions. Their core technology focuses on genomics, proteomics, transcriptomics, and systems biology, enhanced by machine learning and AI. They offer a user-friendly, AI-driven platform for building predictive models and have developed specific software tools like DPhenomics, MSDanalyser, and BMfinder. Their business model is primarily SaaS, with solutions offered as microservices via API or online platforms, utilizing personalized subscription plans. The company is actively involved in scientific publication and software releases, aiming to improve biomarker discovery, diagnostics, prognostics, and therapy assessment in areas like precision medicine.